Form 4: Edwards Lifesciences Executive Larry L. Wood Reports Stock Disposal for Tax Obligations
SEC Form 4 Filing
Larry L. Wood, Global President of TAVR & Surg at Edwards Lifesciences, disposed of 988 shares of common stock to cover tax obligations.
Summary
- On May 11, 2025, Larry L. Wood, Global President TAVR & Surg at Edwards Lifesciences, disposed of 988 shares of common stock.
- The transaction was executed at a price of $73.68 per share.
- Following the transaction, Wood directly owns 206,900.3913 shares of Edwards Lifesciences common stock.
- Wood also indirectly owns 148.1703 shares through a 401(k) plan.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the filing represents a routine transaction for tax purposes and does not indicate any significant positive or negative implications for the company.
Industry Context
Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company executives and directors. This filing indicates a standard transaction for covering tax obligations related to stock-based compensation.
Stakeholder Impact
- The transaction is unlikely to have a significant impact on shareholders as it is a routine disposal of shares for tax purposes.
Key Dates
| Date | Description |
|---|---|
| 05/11/2025 | Date of stock disposal transaction. |
| 05/12/2025 | Date of signature by Attorney-in-Fact. |
Keywords
Form 4, Beneficial Ownership, Edwards Lifesciences, EW, Larry L. Wood, Stock Disposal, TAVR & Surg, Tax Obligations
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.